Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4

2(50.0%)

Phase 3

1(25.0%)

Phase 2

1(25.0%)

4Total

Phase 4(2)

Phase 3(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT03901144Phase 2Completed

A NOVel Moisturiser for Atopic Dermatitis: Effect on the Skin Barrier

Role: lead

NCT00576238Phase 3Completed

Skin Tolerance Study of Betamethasone Creams in Atopic Eczema and the Preventative Properties of a Moisturiser

Role: lead

NCT00771121Phase 4Unknown

Effect of Moisturizing Creams on Skin Barrier Function

Role: lead

NCT00576550Phase 4Completed

A Randomised Trial of a Moisturising Cream in Preventing Recurrence of Hand Eczema

Role: lead

All 4 trials loaded